PODCAST: The Importance of Roadmaps to Digital Transformation Success in the Pharmaceutical Industry
​In this episode of the Westbourne podcast, David Tucker, IT Program Manager at Westbourne, explains the critical role of roadmaps in achieving digital transformation success. The focus of the conversation is the use of digital transformation roadmaps in the pharmaceutical sector.
David explores the current state of digital transformation in pharma laboratories, highlighting the challenges. He emphasizes that many labs still lag behind in their digital journeys. This is a reality that necessitates a structured approach to transformation that can be achieved by developing and following a digital transformation roadmap.
David also explains that a digital transformation roadmap should serve as a strategic guide, outlining the systems to be implemented, the processes that need to change, and the training required for personnel. He discusses the importance of stakeholder buy-in and how a well-structured roadmap can help mitigate skepticism among employees.
For more information on digital transformation roadmaps and the process of modernizing your laboratory, contact us at Westbourne.
Latest Insights
IT Support On-Site – How to Choose the Right Solution for Your Business
Most businesses require some level of IT support, from full support to augmenting in-house technical teams. While there are different types and levels of IT support, most fall into two main categories: remote and on-site. In this blog, we are focusing on IT support...
The Challenges of Computer System Validation in Growing Pharmaceutical Companies
Computer system validation in the pharmaceutical industry is a necessary but typically onerous, challenging, and...
Microsoft 365 – Why It’s Better
Microsoft 365 is Microsoft’s productivity platform. It was formerly known as Microsoft Office 365 and features some of the most commonly used business apps, including Word, Excel, PowerPoint, Outlook, and Teams. Why is Microsoft 365 better than the alternatives and
Ransomware – The Facts
All businesses and organisations are at risk from ransomware. For many of those companies, the risks are substantial and potentially existential, but they are largely contained within the business and its customers. For companies in other sectors, the risks that ransomware poses are much more significant.
Ensuring GMP Compliance with Lab IT Infrastructure and Systems
Continuous improvement is an essential priority for pharmaceutical manufacturers. This push for continuous improvement...

